Tag Influenza
Nasal spray flu vaccine candidate based on UW–Madison technology shows promise when administered alongside high dose annual shot
A unique influenza vaccine candidate that’s inhaled rather than injected is safe and could bolster protection against seasonal and pandemic influenza for people vulnerable to severe disease when they receive it in addition to the annual flu shot.
Raw milk is risky, but airborne transmission of H5N1 from cow’s milk is inefficient in mammals.
New research suggests that exposure to raw milk infected with the currently circulating virus poses a real risk of infecting humans, but that the virus may not spread very far or quickly to others.
Raw milk containing H5N1 can infect mice, while lab-based heat treatments greatly reduce the virus
According to new research from UW–Madison, consuming raw cow's milk that contains H5N1 avian influenza virus poses an infection risk, but a laboratory process that simulates high-temperature pasteurization reduces the virus in infected milk by more than 99.99%.
Air sampling at schools accurately detects flu and COVID-19 virus levels
A new study from the Wisconsin School of Medicine and Public Health found that air samplers placed in school cafeterias provided an accurate read of flu and COVID-19 infections in a K-12 school district.
UW–Madison researchers reveal how key protein might help influenza A infect its hosts
Scientists have found that a key viral protein produced by influenza A can shred a host cell's genetic materials while leaving the virus unharmed.
Wisconsin fox kits test positive for highly pathogenic avian influenza
It’s likely the foxes contracted the virus after eating or coming into contact with infected birds. Humans remain at low risk for developing HPAI infection, but should refrain from approaching sick or dead wildlife.
New vaccine strategy harnesses ‘foot soldier’ T-cells to provide protection against influenza
Researchers believe the same approach can be applied to several other respiratory pathogens, including the novel coronavirus that causes COVID-19.
Avoiding misinformation about COVID-19 and influenza research
Read in Spanish Misinformation with respect to science is not new, but it can be particularly troublesome and even dangerous during the…
UW–Madison, FluGen, Bharat Biotech to develop CoroFlu, a coronavirus vaccine
Refinement of the CoroFlu vaccine concept and testing in laboratory animal models at UW–Madison is expected to take three to six months. CoroFlu could be in human clinical trials by fall, 2020.
UW Shelter Medicine assists with cases of influenza in shelter dogs
Nine dogs in two Oakland, California, animal shelters have tested positive for canine influenza. The UW School of Veterinary Medicine is working closely with the shelters to manage the cases and implement precautionary measures.
Scientists take a journey into the lungs of mice infected with influenza
Using a new tool they call FluVision, UW–Madison researchers can witness an influenza infection in a living animal in action, helping them better understand what happens when a virus infects the lungs and the body responds.
H7N9 influenza is both lethal and transmissible in animal model for flu
“This is the first case of a highly pathogenic avian virus that transmits between ferrets and kills them,” says prominent UW–Madison influenza researcher Yoshihiro Kawaoka. “That’s not good for public health.”
New, more effective strategy for producing flu vaccines
A team of researchers led by Yoshihiro Kawaoka has developed technology that could improve the production of vaccines that protect people from influenza B.
Vaccine trial aims to make flu season safer for heart patients
A network of researchers in the United States and Canada will try to spare thousands of patients the dangers of heart attacks and hospitalizations over the next five years in a trial of a high-dose flu vaccine.
Kawaoka to receive Japan Academy award, presented by Emperor and Empress
Yoshihiro Kawaoka was chosen for his fundamental studies of the influenza virus leading to improved vaccines and better understanding of pandemic flu.
New strategy could yield more precise seasonal flu vaccine
The new approach would better forecast the naturally occurring mutations that help seasonal flu virus dodge vaccines.
Boundless Together, Part 3
The third of four new commercials about UW–Madison will soon premier during a Badger football game. Learn more about the projects highlighted in the latest spot.
Flu study, on hold, yields new vaccine technology
Vaccines to protect against an avian influenza pandemic as well as seasonal flu may be mass produced more quickly and efficiently using technology described today (Sept. 2) by researchers at the University of Wisconsin–Madison in the journal Nature Communications.
Helping in the fight against avian flu
Avian influenza has made headlines in Wisconsin and several other states in recent weeks. The University of Wisconsin–Madison and the Wisconsin Veterinary Diagnostic Laboratory (WVDL) are on the front line in responding to and understanding the virus and providing critical testing for food producers and commercial and private flock owners.
Halting the hijacker: Cellular targets to thwart influenza virus infection
The influenza virus, like all viruses, is a hijacker. It quietly slips its way inside cells, steals the machinery inside to make more copies of itself, and then - having multiplied - bursts out of the cell to find others to infect.